515 filings
Page 3 of 26
SC 13G/A
z2w3ujsex69j0gl5
4 Feb 20
GT Biopharma, Inc.
2:53pm
SC 13G/A
nipepj7om9kkh
16 Jan 20
GT Biopharma, Inc.
4:30pm
EFFECT
a1o7njto8unl vuc8
3 Oct 19
Notice of effectiveness
12:15am
CORRESP
bvz0a 1r3gbllwgc
26 Sep 19
Correspondence with SEC
12:00am
8-K
oykuw 6kf
24 Sep 19
GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to Das Therapeutics
8:00am
UPLOAD
xefb8efrf1rrp
20 Sep 19
Letter from SEC
12:00am
8-K
sld3uhfsnc7u6cadu
23 Aug 19
Entry into a Material Definitive Agreement
5:14pm
4
szh5n9gsn0149 ul2g
16 Aug 19
GT Biopharma / Tony Cataldo ownership change
4:57pm
4
e5c 1jclk4785eh
16 Aug 19
GT Biopharma / Steven W Weldon ownership change
4:51pm
EFFECT
v1ha44m26a1d0k5yfmi
15 Jul 19
Notice of effectiveness
12:15am
CORRESP
4o0fxex1k 09
8 Jul 19
Correspondence with SEC
12:00am
UPLOAD
ddv2kwfxq46 oxgv8
2 Jul 19
Letter from SEC
12:00am
8-K
moq bbr29
24 May 19
Entry into a Material Definitive Agreement
6:14am
8-K
jq29gr8
19 Apr 19
Unregistered Sales of Equity Securities
4:23pm